Benign prostatic hypertrophy (BPH) is relatively common and potentially bothersome to aging men. See Therapeutics Letter #19 (May/June 1997) for background information.1 This Letter updates the evidence of benefit and harm from alpha blockers and...
Maclure M, Nguyen A, Carney G, Dormuth C, Roelants H, Ho K, Schneeweiss S Link to publication...
Overactive Bladder Syndrome (OAB) refers to individuals with the following symptoms: urinary urgency, excessive urinary frequency, or urge incontinence.1 These symptoms are not life threatening, but can cause embarrassment. Incontinence, the most problematic symptom, predominantly...
Three acetylcholinesterase inhibitors (AChE-I) are licensed for Alzheimer's Disease (AD) in Canada: donepezil (Aricept), rivastigmine (Exelon), and galantamine (Reminyl). In 2004 memantine (Ebixa), a neuro-receptor antagonist, was conditionally approved. What treatment outcomes are important to patients...